Discriminative stimulus effects of the type-4 phosphodiesterase inhibitor rolipram in rats

Psychopharmacology

Volumn 158, Issue 3, 2001, Pages 297-304

  Makhay, M M ^a   Houslay, M D ^a   O'Donnell, J M ^a  

^a ACADIA PHARMACEUTICALS INC   (United States)

Author keywords

Antidepressant; Drug discrimination; Operant; Phosphodiesterase; Rat; Rolipram

Indexed keywords

2 AMINO 4,5 DIHYDRO 6 METHYL 5 OXO 4 PROPYL 1,2,4 TRIAZOLO[1,5 A]PYRIMIDINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; BETA ADRENERGIC RECEPTOR; CLENBUTEROL; CYCLIC AMP; DOBUTAMINE; IMIPRAMINE; MILRINONE; NISOXETINE; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IV INHIBITOR; ROLIPRAM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISCRIMINATION LEARNING; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG SPECIFICITY; HYDROLYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE; TASK PERFORMANCE;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, ADRENERGIC, BETA; ROLIPRAM;

EID: 0035164030     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100878     Document Type: Article

References (51)

1. Inhibitors of phosphodiesterase IV (PDE IV) increase acid secretion in rabbit isolated gastric glands: Correlation between function and interaction with a high-affinity rolipram binding site
2. Nootropic drugs have different effects on kindling-induced learning deficits in rats
3. Effects of selective phosphodiesterase inhibition on cyclic AMP hydrolysis in rat cerebral cortical slices
4. 50) of an enzymatic reaction
5. Testing cAMP mediation of memory: Reveral of alpha-methyl-para-tyrosine-induced amnesia
6. Interaction of PDE4 inhibitors with enzymes and cell functions
7. 3H]-rolipram binding activity and their relationship to emetic behavior in the ferret
8. Noradrenergic lesions differentially alter the expression of two subtypes of low Km cAMP-sensitive phosphodiesterase type 4 (PDE4A and PDE4B) in rat brain
9. A multi-center, double-blind study of three different doses of the new cAMP phosphodiesterase inhibitor rolipram in patients with major depressive disorder
10. Antagonism of the response to isoproterenol in the rat hippocampal slice with subtype-selective antagonists
11. On the mechanism by which methylxanthines enhance apomorphine-induced rotation behaviour in the rat
12. Behavioral effects of rolipram and structurally related compounds in mice: Behavioral sedation of cAMP phosphodiesterase inhibitors
13. Role of low-Km cAMP phospho-diesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig
14. Clinical effects of the neurotropic selective cAMP phosphodiesterase inhibitor rolipram in depressed patients: Global evaluation of the preliminary reports
15. Effects of the phospho-diesterase inhibitor rolipram on the acoustic startle response in rats
16. The type IV phosphodiesterase inhibitors, Ro 20-1724 and rolipram, block the initiation of cocaine self-administration
17. Rolipram, an antidepressant that increased the availability of cAMP, transiently enhances wakefulness in rats
18. Effects of antidepressants in rats trained to discriminate the beta-2 adrenergic agonist clenbuterol
19. Discriminative stimulus properties of clenbuterol: Evidence for beta adrenergic involvement
20. The effect of a selective phosphodiesterase inhibitor, rolipram, on muricide in olfactory bulbectomized rats
21. Behavioral consequences of activation of beta adrenergic receptors by clenbuterol: Evidence for mediation by the central nervous system
22. Effects of clenbuterol and other beta adrenergic agonists on locomotor activity
23. Behavioral effects of family-selective inhibitors of cyclic nucleotide phosphodiesterases
24. Agonist interactions on central beta-1 and beta-2 adrenergic receptors of the rat
25. Rolipram forms a potent discriminative stimulus in drug discrimination experiments in rats
26. Antidepressant effects of rolipram in a genetic model of depression
27. Brain cyclic AMP and memory in mice
28. Emesis induced by inhibitors of type IV cyclic nucleotide phosphodiesterase (PDE IV) in the ferret
29. Calcium-dependent phosphodiesterase inhibitors as putative anti-depressants
30. Discriminative stimulus control with imipramine: Transfer to other anti-depressants
31. Close correlation between behavioural response and binding in vivo for inhibitors of the rolipram-sensitive phosphodiesterase
32. Stereospecific binding of the antidepressant to brain protein structures
33. Discriminative stimulus properties of the stereoisomers of the phosphodiesterase inhibitor, rolipram
34. Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipram
35. Effects of lithium and rolipram enantiomers on locomotor activity in inbred mice
36. State notation of behavioral procedures
37. Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms
38. Stimulation of beta adrenoreceptors in human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity
39. 1 dopamine receptors
40. Neurotropic effects of the optical isomers of the selective adenosine 3′, 5′ monophosphate phosdiesterase inhibitor rolipram in rats in vivo
41. Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′, 5′-monophosphate phosphodiesterase inhibitors
42. Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyong postsynaptic monoamine receptors
43. Correlation of cell-free brain cyclic nucleotide phosphodiesterase activities to cyclic AMP decay in intact brain slices
44. Rolipram as a discriminative stimuli: Transfer to phosphodiesterase inhibitors
45. Diminished noradrenergic activity in the brain down-regulates type 4 phosphodiesterase in rat cerebral cortex
46. Noradrenergic activity differentially regulates the expression of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase (PDE4) in the rat brain
47. Effects of repeated antide-pressant treatment of type 4A phosphodiesterase (PDE4A) in rat brain
48. Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats
49. Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism